Clinical Trials Logo

Clinical Trial Summary

MACCHUS is a randomized, single-center, controlled, cross-over interventional study in which coronary artery resistances will be measured at baseline and during temporary occlusion of the coronary sinus.

Clinical Trial Description

The aim of this study is to test whether an increase in coronary sinus pressure leads to a change in coronary microvascular resistances in patients with angina pectoris and with an indication to measurement of microvascular function as per clinical guidelines. All patients with a clinical indication for the assessment of microvascular function will be invited to participate and will sign the informed consent at least 24 hours before the study. Patients with an index of microvascular resistances >25 (i.e. evidence of microvascular dysfunction) will undergo study-specific procedures in the same session (i.e. no additional invasive procedure is required for the study). Study-specific procedures include the repetition of the assessment of microvascular resistances at rest and during coronary sinus occlusion. Coronary sinus occlusion will be achieved by inflating a balloon sized to ~70% of the diameter of the coronary sinus. Since the implantation of a coronary sinus reducer is a therapeutic option for this type of patients, also this procedure (inflation of an undersized balloon in the coronary sinus) provides clinically relevant information (sizing of the vessel, effect on microvascular resistances and feasibility of the intervention). The primary goal of the study is to study the effect of coronary sinus occlusion on microvascular resistances at rest and during hyperemia. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05034224
Study type Interventional
Source Johannes Gutenberg University Mainz
Status Recruiting
Phase N/A
Start date August 23, 2021
Completion date August 23, 2024

See also
  Status Clinical Trial Phase
Withdrawn NCT04069234 - Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. Phase 3
Recruiting NCT04614467 - A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction Phase 2
Terminated NCT03236311 - A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI Phase 2
Recruiting NCT04541797 - Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics With Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM) N/A
Recruiting NCT04598308 - EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial
Recruiting NCT04827498 - Myocardial Ischemia Without Obstructive Coronary Stenoses
Not yet recruiting NCT04560829 - Additive Value of Physiology Coronary in Clinical Practice
Recruiting NCT03217227 - Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR
Completed NCT03462017 - Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus Phase 1
Recruiting NCT04131075 - The Cerebral-Coronary Connection (C3) Study
Completed NCT04485234 - Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
Completed NCT03907722 - The 3q25 rs2305619 Polymorphism Associates With Microvascular Obstruction in STEMI